Lv2
134 积分 2023-12-04 加入
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2天前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
18天前
已完结
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction–associated steatohepatitis (MASH) and fibrosis
18天前
已完结
Computer-Aided Drug Discovery for Undruggable Targets
1个月前
已完结
Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
1个月前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
1个月前
已完结
Inclisiran: A Review in Hypercholesterolemia
1个月前
已完结
《中国脑卒中防治报告2021》
4个月前
已完结
Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis
4个月前
已完结
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
5个月前
已完结
皖公网安备34019202002308
